The Influence Of Drugs Bidding System On The Behavior Of Production And Management In Pharmaceutical Enterprise

In recent years, the pharmaceutical industry has been rapid development in ourcountry. There have been more than6000medicine production enterprises in ourcountry, and most of the world’s medicines are able to manufacture in china. Althoughthe development of China’s pharmaceutical industry is very rapid, but also has thesimilar products produced a large number of enterprises, make the medicine marketcompetition more intense. The small pharmaceutical enterprise scale, a large numberof enterprises, the similar products, lack of research and development capabilities andmany other problems, high price strategy is widely used in pharmaceutical companies,pharmaceutical representatives with gold sales promotion, the results will inevitablylead to high prices, the pharmaceutical industry is not in vogue. In order to reduce thefalsely high price of medicine, pharmaceutical circulation order rectification, the stateintroduced drug tender policy. Mention "drug bidding", people’s first reaction is theblack-box operation, grey zone of negative words, as the pharmaceutical industry is inthe process of transition from planned economy to market economy, and the problemof the pharmaceutical industry, was widely criticized, collectively referred to as "thevocabulary of medicine bidding",and it’s not excessive to be considered full ofmoney idea. Based on this grim situation, with the voice of the people "see a doctordifficultly, expensive medical treatment", cure of the state improve the treatment ofsevere illness, and administer the pharmaceutical industry seriously in recent years.The centralized bidding has produced a great influence to the existing production andbusiness model of pharmaceutical enterprises, to reduce the medical enterprise profits.At present, the national non-profit medical institutions must all take the drugcentralized bid procurement, in the hospital, more than90%of the drug from theprocurement channels, drug bidding has become the main way of purchasing medicalinstitutions, pharmaceutical companies and drug whether win the bid is directlyrelated to the survival and development of pharmaceutical enterprises. So, how toadjust and set up the new mode of production and management of drug centralizedbidding and purchasing system, became the facing problems of pharmaceutical enterprises.Firstly, the author understands the status and existing problems of the domestic andforeign drug bidding. Secondly, the author studies the procurement system of Chinapharmaceutical production, development and main contents, especially drug biddingdirectory and "double envelope" bidding system for pharmaceutical enterprisesinfluence, and uses the methods of the literature induction, comparative analysis andtypical investigation and empirical research to conduct the research to the drugbidding system of pharmaceutical enterprises in production and the choice ofmanagement mode with the product life cycle theory; and then the author illustratesthe practical effect of centralized bidding and purchasing system of drug inpharmaceutical enterprises by Ted data statistics and empirical analysis. At last theauthor analyzes the existing problems in current drug bidding and the direction of thenational medical reform, which have affected the development direction ofpharmaceutical enterprises.